用因子设计法设计和开发消炎药萘普生的固体分散体和制剂

Taraka Ramarao Challa, Pathivada SaiKiranmai
{"title":"用因子设计法设计和开发消炎药萘普生的固体分散体和制剂","authors":"Taraka Ramarao Challa, Pathivada SaiKiranmai","doi":"10.55766/sujst-2023-06-e01216","DOIUrl":null,"url":null,"abstract":"Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.","PeriodicalId":509211,"journal":{"name":"Suranaree Journal of Science and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH\",\"authors\":\"Taraka Ramarao Challa, Pathivada SaiKiranmai\",\"doi\":\"10.55766/sujst-2023-06-e01216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.\",\"PeriodicalId\":509211,\"journal\":{\"name\":\"Suranaree Journal of Science and Technology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Suranaree Journal of Science and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55766/sujst-2023-06-e01216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Suranaree Journal of Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55766/sujst-2023-06-e01216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

萘普生是一种非甾体抗炎药(NSAID),可用作镇痛、消炎和解热剂。研究目的研究的主要目标是提高药物的溶解度和溶解速率,以及口服生物利用度。研究方法采用物理混合法、捏合法和溶剂蒸发法制备萘普生固体分散体(SDs)。采用两级因子设计和三个独立组分,即 X1 β-环糊精、X2:Kolliphor p-188 和 X3:PVPK-30,并由设计专家(DOE)进行设计。通过流动参数、物理特性、傅立叶变换红外光谱以及与市售 Naprosyn 和 F2 的对比研究,对配方进行了研究。主要结果:与纯药物相比,固体分散体 SD 的体外性能良好(20 分钟内 100%释放药物),而纯药物需要 80 分钟才能 100%释放药物。纯药物和辅料组合的傅立叶变换红外光谱没有化学作用。F44本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享
查看原文 本刊更多论文
DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH
Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信